Cited by 189Cancer, Hypoxia, and MetabolismCancer Immunotherapy and BiomarkersImmune Cell Function and Interaction

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Hypoxia Induces Escape from Innate Immunity in Cancer Cells via Increased Expression of ADAM10: Role of Nitric Oxide

Barsoum, Ivraym B., Hamilton, Thomas K., Li, Xin, Cotechini, Tiziana, Miles, Ellen A., Siemens, D. Robert, Graham, Charles H.·2011·Cancer Research

DOI 10.1158/0008-5472.can-11-2104

Published version of a preprint

Open this paper in CoChat — free account

Abstract

One key to malignant progression is the acquired ability of tumor cells to escape immune-mediated lysis. Whereas tumor hypoxia is known to play a causal role in cancer metastasis and resistance to therapy, the link between hypoxia and immune escape in cancer remains poorly understood. Here, we show that hypoxia induces tumor cell resistance to lysis mediated by immune effectors and that this resistance to lysis occurs via a hypoxia-inducible factor-1 (HIF-1)–dependent pathway linked to increased expression of the metalloproteinase ADAM10. This enzyme is required for the hypoxia-induced shedding of MHC class I chain–related molecule A (MICA), a ligand that triggers the cytolytic action of immune effectors, from the surface of tumor cells. Indeed, our findings show a mechanistic link between hypoxia-induced accumulation of the α-subunit of HIF-1 (HIF-1α), increased expression of ADAM10, and decreased surface MICA levels leading to tumor cell resistance to lysis mediated by innate immune effectors. Nitric oxide mimetic agents interfered with the hypoxia-induced accumulation of HIF-1α and with the hypoxia-induced upregulation of ADAM10 expression required for decreased surface MICA expression and resistance to lysis. Furthermore, treatment of tumor-bearing mice with nitroglycerin, a nitric oxide mimetic, attenuated tumor growth by a mechanism that relied upon innate immune effector cells. Together, these findings reveal a novel mechanism by which the hypoxic tumor microenvironment contributes to immune escape in cancer, lending support to potential immunotherapeutic strategies involving the use of nitric oxide mimetics. Cancer Res; 71(24); 7433–41. ©2011 AACR.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-11-2104

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J. D., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,674
Hypoxia-Inducible Factor 1 (HIF-1) Pathway
Semenza, G. L. (2007) · Science s STKE · doi:10.1126/stke.4072007cm8 · Cited by 970
Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α
Hagen, T., Taylor, C. T., Lam, F., & Moncada, S. (2003) · Science · doi:10.1126/science.1088805 · Cited by 704
Hypoxia and drug resistance
Teicher, B. A. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689633 · Cited by 563
Untitled work
(1997) · PubMed · Cited by 433
Hypoxia-driven selection of the metastatic phenotype
Sullivan, R., & Graham, C. H. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9062-2 · Cited by 423
Self-citation
Tumor-Associated MICA Is Shed by ADAM Proteases
Waldhauer, I., Goehlsdorf, D., Gieseke, F., Weinschenk, T., Wittenbrink, M., Ludwig, A., Stevanović, S., Rammensee, H., & Steinle, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6768 · Cited by 382
Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer.
Wu, J. D., Higgins, L. M., Steinle, A., Cosman, D., Haugk, K., & Plymate, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22206 · Cited by 365

Show all 29 references

Sorted by citations

Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
Lin, Y., Xu, J., & Lan, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0760-3 · Cited by 1,398
Hypoxic control of metastasis
Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340
Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
Henke, E., Nandigama, R., & Ergün, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00160 · Cited by 1,142
A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells
Barsoum, I. B., Smallwood, C. A., Siemens, D. R., & Graham, C. H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-0992 · Cited by 767
Self-citation
The role of HIF in immunity and inflammation
McGettrick, A. F., & O’Neill, L. A. J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.002 · Cited by 768
The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment
Emami Nejad, A., Najafgholian, S., Rostami, A., Sistani, A., Shojaeifar, S., Esparvarinha, M., Nedaeinia, R., Haghjooy Javanmard, S., Taherian, M., Ahmadlou, M., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01719-5 · Cited by 693
Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
Mohme, M., Riethdorf, S., & Pantel, K. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.144 · Cited by 616
Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect
Rodriguez-Ruiz, M. E., Vanpouille‐Box, C., Melero, I., Formenti, S. C., & Demaria, S. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.06.001 · Cited by 517
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
Noman, M. Z., Hasmim, M., Messai, Y., Terry, S., Kiéda, C., Janji, B., & Chouaı̈b, S. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00207.2015 · Cited by 420
Fighting Immune Cold and Reprogramming Immunosuppressive Tumor Microenvironment with Red Blood Cell Membrane-Camouflaged Nanobullets
Yang, Z., Gao, D., Guo, X., Jin, L., Zheng, J., Wang, Y., Chen, S., Zheng, X., Zeng, L., Guo, M., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c07721 · Cited by 275
The role of hypoxia‐inducible factor 1 in tumor immune evasion
Li, Y., Wu, W., Wang, X., Fang, L., Adam, V., Nepovimová, E., Wu, Q., & Kuča, K. (2020) · Medicinal Research Reviews · doi:10.1002/med.21771 · Cited by 276
NKG2D and Its Ligands: “One for All, All for One”
Zingoni, A., Molfetta, R., Fionda, C., Soriani, A., Paolini, R., Cippitelli, M., Cerboni, C., & Santoni, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00476 · Cited by 267
Hypoxia and acidosis: immune suppressors and therapeutic targets
Damgaci, S., Ibrahim‐Hashim, A., Enríquez‐Navas, P. M., Pilon‐Thomas, S., Güveniş, A., & Gillies, R. J. (2018) · Immunology · doi:10.1111/imm.12917 · Cited by 231
Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy
Gupta, S., Roy, A., & Dwarakanath, B. S. R. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00068 · Cited by 225
Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
Sarkar, S., Germeraad, W. T. V., Rouschop, K. M. A., Steeghs, E. M. P., van Gelder, M., Bos, G. M. J., & Wieten, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064835 · Cited by 222
Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
Noman, M. Z., Hasmim, M., Lequeux, A., Xiao, M., Duhem, C., Chouaı̈b, S., Berchem, G., & Janji, B. (2019) · Cells · doi:10.3390/cells8091083 · Cited by 220
Immune-suppressive properties of the tumor microenvironment
Becker, J. C., Andersen, M. H., Schrama, D., & Straten, P. T. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1434-6 · Cited by 211
Mechanisms of Hypoxia-Mediated Immune Escape in Cancer
Barsoum, I. B., Koti, M., Siemens, D. R., & Graham, C. H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2598 · Cited by 205
Self-citation
The Critical Role of the Tumor Microenvironment in Shaping Natural Killer Cell-Mediated Anti-Tumor Immunity
Bagińska, J., Viry, E., Paggetti, J., Medves, S., Berchem, G., Moussay, E., & Janji, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00490 · Cited by 204
Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis
Ou, Z., Luo, Z., Wei, W., Liang, S., Gao, T.-L., & Lu, Y. (2019) · RNA Biology · doi:10.1080/15476286.2019.1649585 · Cited by 176
Altered cancer metabolism in mechanisms of immunotherapy resistance
Ramapriyan, R., Caetano, M. S., Barsoumian, H. B., Mafra, A. C. P., Zambalde, É. P., Menon, H., Tsouko, E., Welsh, J. W., & Cortez, M. A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.004 · Cited by 173
Arginine and the metabolic regulation of nitric oxide synthesis in cancer
Keshet, R., & Erez, A. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033332 · Cited by 166
A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model
Oh, K., Lee, O.-Y., Shon, S.-Y., Nam, O., Ryu, P. M., Seo, M. W., & Lee, D. (2013) · Breast Cancer Research · doi:10.1186/bcr3473 · Cited by 160
Efficiency and Target Derepression of Anti-miR-92a: Results of a First in Human Study
Abplanalp, W. T., Fischer, A., John, D., Zeiher, A. M., Gosgnach, W., Darville, H., Montgomery, R. L., Pestano, L. A., Allée, G., Paty, I., et al. (2020) · Nucleic Acid Therapeutics · doi:10.1089/nat.2020.0871 · Cited by 163
Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction
McDonald, P. C., Chafe, S. C., & Dedhar, S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00027 · Cited by 154
Immune Response Regulation in the Tumor Microenvironment by Hypoxia
Labiano, S., Palazón, A., & Melero, I. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.02.009 · Cited by 155
Circadian rhythms and cancers: the intrinsic links and therapeutic potentials
Zhou, L., Zhang, Z., Nice, E. C., Huang, C., Zhang, W., & Tang, Y. C. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01238-y · Cited by 163
Hypoxia: a Double-Edged Sword in Cancer Therapy
Manoochehri Khoshinani, H., Afshar, S., & Najafi, R. (2016) · Cancer Investigation · doi:10.1080/07357907.2016.1245317 · Cited by 147
Recent Findings in the Regulation of Programmed Death Ligand 1 Expression
Shen, X., Zhang, L., Li, J., Li, Y., Wang, Y., & Xu, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01337 · Cited by 133
Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy
Fu, Z., Mowday, A. M., Smaill, J. B., Hermans, I. F., & Patterson, A. V. (2021) · Cells · doi:10.3390/cells10051006 · Cited by 133
Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy
Zhong, X., Zhang, H.-T., Zhu, Y., Liang, Y., Yuan, Z., Li, J., Li, X., Li, X., Jia, Y., Tian, H., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-1141-9 · Cited by 133
Self-citation
The HIF target MAFF promotes tumor invasion and metastasis through IL11 and STAT3 signaling
Moon, E. J., Mello, S. S., Li, C. G., Chi, J., Thakkar, K. N., Kirkland, J. G., LaGory, E. L., Lee, I. J., Diep, A. N., Miao, Y. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24631-6 · Cited by 130
Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia
Phung, C. D., Tran, T. H., Pham, L. M., Nguyen, H. T., Jeong, J., Yong, C. S., & Kim, J. O. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.029 · Cited by 115
Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer’s Disease Mouse Model
Guo, C., Yang, Z., Zhang, S., Chai, R., Han, X., Zhang, Y., Li, J., & Wang, Z. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.8 · Cited by 109
Hypoxic Stress-Induced Tumor and Immune Plasticity, Suppression, and Impact on Tumor Heterogeneity
Terry, S., Buart, S., & Chouaı̈b, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01625 · Cited by 111
Fractalkine/CX3CL1 in Neoplastic Processes
Korbecki, J., Simińska, D., Kojder, K., Grochans, S., Gutowska, I., Chlubek, D., & Baranowska‐Bosiacka, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103723 · Cited by 110
Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma
Eckert, A. W., Wickenhauser, C., Salins, P. C., Kappler, M., Bukur, J., & Seliger, B. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0828-6 · Cited by 110
The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?
Jurj, A. M., Ionescu, C., Berindan‐Neagoe, I., & Braicu, C. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02484-1 · Cited by 113
Hypoxia-Induced Resistance to Chemotherapy in Cancer
Minassian, L. M., Cotechini, T., Huitema, E., & Graham, C. H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_9 · Cited by 102
Self-citation
The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance
Dianat‐Moghadam, H., Azizi, M., Eslami‐S, Z., Cortés‐Hernández, L. E., Heidarifard, M., Nouri, M., & Alix‐Panabières, C. (2020) · Cancers · doi:10.3390/cancers12040867 · Cited by 103
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
Codó, P., Weller, M., Meister, G., Szabó, E., Steinle, A., Wolter, M., Reifenberger, G., & Roth, P. (2014) · Oncotarget · doi:10.18632/oncotarget.2287 · Cited by 95
Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors
Chambers, A. M., & Matosevic, S. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00060 · Cited by 100
Overcoming tumor resistance mechanisms in CAR-NK cell therapy
Valeri, A., García-Ortiz, A., Castellano, E., Córdoba, L., Maroto-Martín, E., Encinas, J., Leivas, A., Río, P., & Martínez‐López, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953849 · Cited by 96
Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response
Huang, X., & Zuo, J. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt141 · Cited by 91
Secretory pathways generating immunosuppressive NKG2D ligands
Raneros, A. B., Suárez-Álvarez, B., & López-Larrea, C. (2014) · Oncoimmunology · doi:10.4161/onci.28497 · Cited by 82
Melatonin stimulates the nonamyloidogenic processing of β APP through the positive transcriptional regulation of ADAM10 and ADAM17
Shukla, M., Htoo, H. H., Wintachai, P., Hernandez, J., Dubois, C. M., Postina, R., Xu, H., Checler, F., Smith, D. R., Govitrapong, P., et al. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12200 · Cited by 88
Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours
Shenouda, M. M., Gillgrass, A. E., Nham, T., Hogg, R. T., Lee, A. J., Chew, M. V., Shafaei, M., Aarts, C. W., Lee, D. A., Hassell, J. A., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0867-9 · Cited by 80
Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future
Lamb, M. G., Rangarajan, H. G., Tullius, B. P., & Lee, D. A. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02277-x · Cited by 79
Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells
Chambers, A. M., Lupo, K. B., & Matosevic, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02517 · Cited by 79
Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
Yuan, C.-S., Deng, Z., Qin, D., Mu, Y., Chen, X., & Liu, Y. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.02.030 · Cited by 71
NKG2D Ligand Shedding in Response to Stress: Role of ADAM10
Zingoni, A., Vulpis, E., Loconte, L., & Santoni, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00447 · Cited by 59
Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers
Zhang, H., Cao, K., Xiang, J., Zhang, M., Zhu, M., & Xi, Q. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216345 · Cited by 68
Combining Antiangiogenic Therapy with Adoptive Cell Immunotherapy Exerts Better Antitumor Effects in Non-Small Cell Lung Cancer Models
Shi, S., Wang, R., Chen, Y., Song, H., Chen, L., & Huang, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065757 · Cited by 66
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation
Fionda, C., Abruzzese, M. P., Zingoni, A., Soriani, A., Ricci, B., Molfetta, R., Paolini, R., Santoni, A., & Cippitelli, M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1023-5 · Cited by 65
Gain of HIF-1α under Normoxia in Cancer Mediates Immune Adaptation through the AKT/ERK and VEGFA Axes
Lee, Y.-H., Bae, H. C., Noh, K. H., Song, K.-H., Ye, S.-K., Mao, C.-P., Lee, K.-M., Wu, T.-C., & Kim, T. W. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1979 · Cited by 64
Association of PD-L1 and HIF-1α Coexpression with Poor Prognosis in Hepatocellular Carcinoma
Dai, X., Pi, G., Yang, S., Chen, G. Y., Liu, L., & Dong, H. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.02.014 · Cited by 63
Hypoxia-inducible factors as key regulators of tumor inflammation
Mamlouk, S., & Wielockx, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.27901 · Cited by 61
Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner
Yamada, N., Yamanegi, K., Ohyama, H., Hata, M., Nakasho, K., Futani, H., Okamura, H., & Terada, N. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1630 · Cited by 62
Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors
Eckert, F., Zwirner, K., Boeke, S., Thorwarth, D., Zips, D., & Huber, S. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00407 · Cited by 61
Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions
Kravchenko, J. S., Corsini, E., Williams, M. A., Decker, W. K., Manjili, M. H., Otsuki, T., Singh, N., Al‐Mulla, F., Al-Temaimi, R. A., Amedei, A., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv033 · Cited by 60
Signal Propagation in Protein Interaction Network during Colorectal Cancer Progression
Jiang, Y., Huang, T., Chen, L., Gao, Y., Cai, Y., & Chou, K. (2013) · BioMed Research International · doi:10.1155/2013/287019 · Cited by 58
Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment
Jiang, Z., Hsu, J. L., Li, Y., Hortobágyi, G. N., & Hung, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01197 · Cited by 62
Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent
Sukhatme, V. V., Bouche, G., Meheus, L., Sukhatme, V. P., & Pantziarka, P. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.568 · Cited by 56
Tuning cancer fate: the unremitting role of host immunity
Calì, B., Molon, B., & Viola, A. (2017) · Open Biology · doi:10.1098/rsob.170006 · Cited by 57
Radiotherapy in Combination With Cytokine Treatment
Palata, O., Podzimkova, N., Nedvedova, E., Umprecht, A., Sadilkova, L. K., Jelinkova, L. P., Špíšek, R., & Adkins, I. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00367 · Cited by 52
Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy
Khouzam, R. A., Janji, B., Thiery, J., Zaarour, R. F., Chamseddine, A. N., Mayr, H., Savagner, P., Kiéda, C., Gad, S., Buart, S., et al. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.008 · Cited by 54
Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and “swarm intelligence”
Tarabichi, M., Antoniou, A., Saiselet, M., Pita, J. M. G., Andry, G., Dumont, J. E., Detours, V., & Maenhaut, C. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9431-y · Cited by 51
An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment
Khouzam, R. A., Rao, R. S. P., Venkatesh, G. H., Zeinelabdin, N. A., Buart, S., Meylan, M., Nimmakayalu, M. A., Terry, S., & Chouaı̈b, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.680435 · Cited by 50
The Effect of Disintegrin–Metalloproteinase ADAM9 in Gastric Cancer Progression
Kim, J., Jeung, H., Rha, S. Y., Yu, E., Kim, T. S., Shin, Y. K., Zhang, X., Park, K.-H., Park, S. W., Chung, H. C., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-1001 · Cited by 48
Natural Killer Cell-Based Immunotherapy against Glioblastoma
Morimoto, T., Nakazawa, T., Maeoka, R., Nakagawa, I., Tsujimura, T., & Matsuda, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032111 · Cited by 51
NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment
de la Calle‐Fabregat, C., Calafell-Segura, J., Gardet, M., Dunsmore, G., Mulder, K., Ciudad, L., Silvin, A., Moreno‐Càceres, J., Corbí, A. L., Muñoz‐Pinedo, C., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq5226 · Cited by 50
Tumor Necrosis Factor Alpha-Induced Hypoxia-Inducible Factor 1α–β-Catenin Axis Regulates Major Histocompatibility Complex Class I Gene Activation through Chromatin Remodeling
Ghosh, S., Paul, A., & Sen, E. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01254-12 · Cited by 47
Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer
Hamilton, T. K., Hu, N., Kolomitro, K., Bell, E. N., Maurice, D. H., Graham, C. H., & Siemens, D. R. (2012) · World Journal of Urology · doi:10.1007/s00345-012-0848-7 · Cited by 47
Self-citation
The Reactive Species Interactome in the Brain
Malard, E., Valable, S., Bernaudin, M., Pérès, E. A., & Châtre, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8238 · Cited by 49
Sensors, Transmitters, and Targets in Mitochondrial Oxygen Shortage—A Hypoxia-Inducible Factor Relay Story
Dehne, N., & Brüne, B. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4776 · Cited by 44
Cell Death Conversion under Hypoxic Condition in Tumor Development and Therapy
Qiu, Y., Li, P., & Ji, C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025536 · Cited by 46
Regulation of the α-secretase ADAM10 at transcriptional, translational and post-translational levels
Vincent, B. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.020 · Cited by 45
ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker
Yoneyama, T., Gorry, M. C., Sobo-Vujanovic, A., Lin, Y., Vujanovic, L. N., Gaither‐Davis, A., Moss, M. L., Miller, M. A., Griffith, L. G., Lauffenburger, D. A., et al. (2018) · Journal of Cancer · doi:10.7150/jca.24601 · Cited by 44
Disseminated tumour cells in bone marrow are the source of cancer relapse after therapy
Sai, B., & Xiang, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13867 · Cited by 44
The Impact of Obesity, Adipose Tissue, and Tumor Microenvironment on Macrophage Polarization and Metastasis
Habanjar, O., Diab‐Assaf, M., Caldefie‐Chezet, F., & Delort, L. (2022) · Biology · doi:10.3390/biology11020339 · Cited by 41
Novel role of immune-related non-coding RNAs as potential biomarkers regulating tumour immunoresponse via MICA/NKG2D pathway
Zhang, J., Luo, Q., Li, X., Guo, J., Zhu, Q. K., Lu, X., Wei, L., Xiang, Z., Peng, M., Ou, C., et al. (2023) · Biomarker Research · doi:10.1186/s40364-023-00530-4 · Cited by 41
Self-citation
Nitric Oxide and Immune Responses in Cancer: Searching for New Therapeutic Strategies
Sahebnasagh, A., Saghafi, F., Negintaji, S., Hu, T., Shabani-Borujeni, M., Safdari, M., Ghaleno, H. R., Miao, L., Qi, Y., Wang, M., et al. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210707194543 · Cited by 39
Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer
Russell, É., Conroy, M. J., & Barr, M. P. (2022) · Cells · doi:10.3390/cells11040605 · Cited by 37
Functional Plasticity of Gamma Delta T Cells and Breast Tumor Targets in Hypoxia
Siegers, G. M., Dutta, I., Lai, R. L., & Postovit, L.-M. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01367 · Cited by 38
Circular RNA and tumor microenvironment
Song, H., Liu, Q., & Liao, Q. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01301-z · Cited by 37
β-defensin-3 negatively regulates TLR4–HMGB1 axis mediated HLA-G expression in IL-1β treated glioma cells
Gupta, P., Ghosh, S., Nagarajan, A., Mehta, V. S., & Sen, E. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.12.001 · Cited by 36
Histo-genomics: digital pathology at the forefront of precision medicine
Barsoum, I. B., Tawedrous, E., Faragalla, H., & Yousef, G. M. (2018) · Diagnosis · doi:10.1515/dx-2018-0064 · Cited by 34
Self-citation
A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells
Schilling, D., Tetzlaff, F., Konrad, S., Li, W., & Multhoff, G. (2014) · Cell Stress and Chaperones · doi:10.1007/s12192-014-0532-5 · Cited by 32
Obstructive Sleep Apnea Monocytes Exhibit High Levels of Vascular Endothelial Growth Factor Secretion, Augmenting Tumor Progression
Cubillos-Zapata, C., Hernández-Jiménez, E., Avendaño-Ortiz, J., Toledano, V., Varela-Serrano, A., Fernández-Navarro, I., Casitas, R., Carpio, C., Aguirre, L. A., García-Río, F., et al. (2018) · Mediators of Inflammation · doi:10.1155/2018/7373921 · Cited by 31
Post-translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention
Molfetta, R., Zingoni, A., Santoni, A., & Paolini, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02557 · Cited by 26
Hypoxic tumor microenvironment: Destroyer of natural killer cell function
Zhang, Y., Guo, F., & Wang, Y. (2024) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2024.02.04 · Cited by 32
IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM)
Wege, A. K., Weber, F., Kroemer, A., Ortmann, O., Nimmerjahn, F., & Brockhoff, G. (2016) · Oncotarget · doi:10.18632/oncotarget.13159 · Cited by 30
Hijacker of the Antitumor Immune Response: Autophagy Is Showing Its Worst Facet
Viry, E., Noman, M. Z., Arakelian, T., Lequeux, A., Chouaı̈b, S., Berchem, G., Moussay, E., Paggetti, J., & Janji, B. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00246 · Cited by 31
Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity
Lin, H.-J. L., Liu, Y., Lofland, D., & Lin, J. (2022) · Cancers · doi:10.3390/cancers14020285 · Cited by 28
Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance
Aria, H., Rezaei, M., Nazem, S., Daraei, A., Nikfar, G., Mansoori, B., Bahmanyar, M., Tavassoli, A., Vakil, M. K., & Mansoori, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.947885 · Cited by 26
Tumor Immune Microenvironment in Gynecologic Cancers
Margul, D. J., Yu, C., & AlHilli, M. M. (2023) · Cancers · doi:10.3390/cancers15153849 · Cited by 24
Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel
Kapur, N., Mir, H., Sonpavde, G., Jain, S. R., Bae, S., Lillard, J. W., & Singh, S. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.001 · Cited by 26
The role of tumor-associated macrophages and soluble mediators in pulmonary metastatic melanoma
Xiong, K., Qi, M., Stoeger, T., Zhang, J., & Chen, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1000927 · Cited by 26
SEP enhanced the antitumor activity of 5-fluorouracil by up-regulating NKG2D/MICA and reversed immune suppression via inhibiting ROS and caspase-3 in mice
Ke, M., Wang, H., Zhou, Y., Li, J., Liu, Y., Zhang, M., Dou, J., Xi, T., Shen, B., & Zhou, C. (2016) · Oncotarget · doi:10.18632/oncotarget.10375 · Cited by 23
Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities
Zhang, W., Jin, C., Liu, S., Wan, X., Li, Y., Liu, J., Duan, Z., Ma, J., & Gao, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1757513 · Cited by 22

Authors: Barsoum, I. B., Hamilton, T. K., Li, X., Cotechini, T., Miles, E. A., Siemens, D. R., & Graham, C. H.
Affiliations: Queen's University (CA)
ORCID: Cotechini, Tiziana
Miles, Ellen A.
Siemens, D. Robert
Graham, Charles H.
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2011-12-15
Volume: 71
Issue: 24
Pages: 7433-7441
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-11-2104
OpenAlex: W1969090863
Cited by: 188
References: 29
Citations by year: 2026: 9 · 2025: 13 · 2024: 6 · 2023: 19 · 2022: 22 · 2021: 16 · 2020: 16 · 2019: 14 · 2018: 13 · 2017: 7 · 2016: 11 · 2015: 14 · 2014: 9 · 2013: 10 · 2012: 9
FWCI: 3.05
Type: journal article
Language: en
Open access: closed
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
Keywords: tumor hypoxia, immune evasion, ADAM10, nitric oxide, HIF-1α, nitroglycerin, tumor microenvironment, immunotherapy
MeSH terms: ADAM10 Protein, Animals, Flow Cytometry, Nitroglycerin, Humans, Immunity, Innate, Membrane Proteins, Mice, Nude, Neoplasms, Neoplasms, Experimental, Nitric Oxide, Transplantation, Heterologous, Vasodilator Agents, Blotting, Western, Histocompatibility Antigens Class I, Cell Hypoxia, RNA Interference, Cell Line, Tumor, Tumor Burden, Mice, ADAM Proteins, Hypoxia-Inducible Factor 1, alpha Subunit, Amyloid Precursor Protein Secretases, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoxia Induces Escape from Innate Immunity in Cancer Cells via Increased Expression of ADAM10: Role of Nitric Oxide

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks